V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014663 | 160007220 | 1.88 | 105.4 | Palliative (P) | 2018-02-22 | 2018-02-24 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101406036 |
| 160014667 | 160007222 | 1.82 | 69.2 | Palliative (P) | 2020-10-02 | 2020-10-30 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 100835301 |
| 160014668 | 160007223 | null | null | null | 2018-01-21 | 2018-01-29 | Cisplatin + Pemetrexed | 02 | Y | CISPLATIN + PEMETREXED | 100060290 |
| 160014670 | 160007224 | 1.83 | 89.3 | Palliative (P) | 2019-05-03 | 2019-06-19 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100298818 |
| 160014672 | 160007225 | 1.78 | 51.8 | Palliative (P) | 2018-03-22 | 2018-05-01 | Cisplatin + Pemetrexed | 02 | Y | CISPLATIN + PEMETREXED | 100578864 |
| 160014676 | 160007227 | 1.65 | 65.1 | 03 | 2017-03-19 | 2017-03-27 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100667157 |
| 160014677 | 160007228 | 1.7 | 83.9 | Palliative (P) | 2018-10-15 | 2018-10-21 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 101441204 |
| 160014678 | 160007229 | 1.88 | 77.3 | Adjuvant (A) | null | 2019-02-05 | EOX | null | N | TRIAL | 100381152 |
| 160014682 | 160007230 | 0 | 11.3 | Neo-adjuvant (N) | 2017-03-01 | 2017-04-26 | Doxorubicin 75mg/m2 | 01 | N | ETOP 13-18 BEAT-MESO TRIAL | 101643280 |
| 160014683 | 160007231 | 1.76 | 47 | Curative (C) | 2016-03-27 | 2016-04-09 | null | 02 | N | PACLITAXEL | 101665060 |
| 160014686 | 160007232 | 1.76 | 90.8 | Palliative (P) | 2018-11-12 | 2018-12-04 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 100938654 |
| 160014687 | 160007233 | 1.65 | 57.4 | Palliative (P) | 2018-10-20 | 2018-10-21 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 100823006 |
| 160014689 | 160007234 | 1.78 | 58.6 | Palliative (P) | 2019-11-26 | 2019-11-26 | Doxorubicin + Ifosfamide | null | N | LIPOSOMAL DOXORUBICIN | 100753339 |
| 160014690 | 160007235 | 1.67 | 77.4 | 03 | 2018-04-16 | 2018-05-03 | Pazopanib | null | N | NB HRNBL-1 COJEC IND COURSE A | 101082282 |
| 160014694 | 160007237 | 1.84 | 64.5 | Neo-adjuvant (N) | 2019-10-25 | 2019-11-08 | ECX | null | N | ETOP 13-18 BEAT-MESO TRIAL | 101702549 |
| 160014695 | 160007238 | 1.72 | 68.2 | Neo-adjuvant (N) | 2018-09-07 | 2018-09-07 | Doxorubicin + Olaratumab | N | N | DOXORUBICIN | 101332444 |
| 160014696 | 160007239 | 1.8 | 94 | null | 2019-05-19 | 2019-05-19 | null | N | Y | DOCETAXEL | 100562745 |
| 160014697 | 160007240 | 1.78 | 98.6 | Not known (9) | 2018-11-13 | 2018-11-13 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100292100 |
| 160014698 | 160007241 | 1.62 | 76.15 | Palliative (P) | 2019-09-28 | 2019-10-13 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 101222616 |
| 160014703 | 160007242 | 1.7 | 87 | Curative (C) | 2016-04-08 | 2016-04-08 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100582055 |
| 160014705 | 160007243 | 1.58 | 95 | Adjuvant (A) | 2017-01-24 | 2017-02-10 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100169690 |
| 160014712 | 160007244 | 1.6 | 27.1 | null | 2019-06-19 | 2019-06-19 | Pemetrexed | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101382190 |
| 160014714 | 160007245 | 1.57 | 113 | null | 2019-07-05 | 2019-07-19 | Dactinomycin + Vincristine | 02 | null | CARBOPLATIN + PACLITAXEL | 100255650 |
| 160014715 | 160007246 | 1.61 | 60.55 | Curative (C) | 2021-05-05 | 2021-05-05 | PACLITAXEL | 02 | N | CISPLATIN + PEMETREXED | 101377815 |
| 160014718 | 160007248 | 1.78 | 75.2 | Curative (C) | 2016-07-01 | 2016-07-19 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101711582 |
| 160014719 | 160007249 | 1.6 | 48.2 | Curative (C) | 2016-02-14 | 2016-02-27 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | N | DOXORUBICIN + OLARATUMAB | 101646654 |
| 160014720 | 160007250 | 0.6 | 88 | Neo-adjuvant (N) | 2017-12-15 | 2017-12-16 | MELPHALAN | 02 | N | BEVACIZUMAB + CARBO + PACLITAXEL | 100812443 |
| 160014721 | 160007251 | 1.6 | 67.1 | Not known (9) | 2015-11-02 | 2015-11-03 | Cisplatin + Pemetrexed | 02 | N | TRIAL UNSPECIFIED | 100044358 |
| 160014722 | 160007252 | 1.77 | 76.4 | null | 2019-05-01 | 2019-05-05 | VIDE | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100901395 |
| 160014725 | 160007253 | 1.75 | 72.5 | Curative (C) | 2016-09-05 | 2016-09-14 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100408542 |
| 160014727 | 160007254 | 1.8 | 79.7 | Disease modification (D) | 2018-02-26 | 2018-03-26 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 101054950 |
| 160014728 | 160007255 | 1.72 | 60.9 | Palliative (P) | 2017-06-11 | 2017-06-12 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100566079 |
| 160014729 | 160007256 | 1.75 | 63.4 | Palliative (P) | 2018-09-11 | 2018-09-23 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 100174454 |
| 160014730 | 160007257 | 1.56 | 57.2 | null | 2022-04-05 | 2022-04-05 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100808923 |
| 160014731 | 160007258 | 1.64 | 73.4 | Palliative (P) | 2019-09-12 | 2019-09-26 | Carboplatin + Paclitaxel (weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100750436 |
| 160014732 | 160007259 | 1.56 | 58.5 | Neo-adjuvant (N) | 2016-12-11 | 2016-12-15 | GEMCARBO | 02 | N | DOXORUBICIN | 101496180 |
| 160014734 | 160007260 | 1.55 | 58.75 | Palliative (P) | 2017-08-24 | 2017-08-24 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101618920 |
| 160014735 | 160007261 | null | null | Palliative (P) | 2016-07-10 | 2016-07-11 | ETOP 13-18 BEAT-meso Trial | 02 | null | CISPLATIN + PACLITAXEL | 101134390 |
| 160014736 | 160007262 | 1.79 | 94.4 | Palliative (P) | 2019-03-10 | 2019-03-23 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100756121 |
| 160014742 | 160007263 | 1.76 | 71.6 | Palliative (P) | 2017-10-19 | 2017-10-24 | Cisplatin + Pemetrexed | 02 | Y | CISPLATIN + PEMETREXED | 101359620 |
| 160014743 | 160007264 | 1.75 | 76.9 | Palliative (P) | 2016-03-25 | 2016-04-08 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | Y | CARBOPLATIN + PACLITAXEL | 101104487 |
| 160014746 | 160007265 | 1.55 | 52 | Palliative (P) | 2018-05-12 | 2018-05-21 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | GC INT GUIDE EXCRANIAL GERMCELL JEB | 101188511 |
| 160014747 | 160007266 | 1.8 | 101.95 | Palliative (P) | 2017-11-06 | 2017-11-30 | Cisplatin + Pemetrexed | 2 | N | DOXORUBICIN + IFOSFAMIDE | 101392349 |
| 160014749 | 160007267 | 1.52 | 69 | null | 2018-02-25 | 2018-03-02 | Cisplatin + Pemetrexed | 2 | null | CISPLATIN + PEMETREXED | 101504366 |
| 160014751 | 160007268 | null | null | null | null | 2020-05-04 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 101553282 |
| 160014754 | 160007269 | 1.57 | 75.6 | Palliative (P) | 2018-09-19 | 2018-09-25 | GC Int Guide Excranial GermCell JEB | 02 | null | CAP | 100313680 |
| 160014755 | 160007270 | 0 | 35.1 | Curative (C) | 2017-10-24 | 2017-11-01 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101771985 |
| 160014757 | 160007271 | 1.78 | 79.6 | Palliative (P) | null | 2016-07-24 | Doxorubicin + Ifosfamide | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100354499 |
| 160014758 | 160007272 | 1.68 | 76.7 | Neo-adjuvant (N) | 2019-05-05 | 2019-05-07 | Enzalutamide | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 100906401 |
| 160014759 | 160007273 | 1.83 | 53.4 | Palliative (P) | null | 2018-12-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101321280 |